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STATE-OF-THE-ART PAPER STATE-OF-THE-ART PAPER1753Preparing the United States for High-Sensitivity Cardiac Troponin AssaysFrederick K. Korley, Allan S. Jaffe
It is only a matter of time before the use of high-sensitivity cardiac troponin assays becomes
common throughout the United States. These assays hold the promise of improving the
sensitivity of acute myocardial infarction (AMI) diagnoses, shortening the duration of AMI
evaluation, and improving the risk stratification of other noncardiac diagnoses.
However, given that detectable levels are present in approximately 2% of healthy
individuals with higher rates in hospitalized patients, additional studies and clarifications
are needed to prevent confusion and overdiagnosis of acute coronary syndromes.CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGY
17595-Year Experience With Transapical Mitral
TVIV for Bioprosthetic Valve DysfunctionAnson Cheung, John G. Webb, Marco Barbanti, Melanie Freeman, Ronald K. Binder, Christopher Thompson,
David A. Wood, Jian Ye
Transcatheter valve-in-valve implantation (TVIV) may be a lower risk alternative for high-
risk patients with degeneration of a previously placed bioprosthetic mitral valve. Cheung and
colleagues report on 23 consecutive patients who underwent transapical mitral TVIV. All
patients were elderly and at high risk for conventional re-do surgery. Successful TVIV was
accomplished in all patients with no intraoperative major complications. One (4.4%) major
stroke and 6 (26.1%) major bleeds were reported during hospitalization. Mitral transvalvular
gradient significantly decreased; mitral regurgitation was absent or mild in all cases. At a
median follow-up of 2 years, survival was 87%.(continued on page A-18)
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1767Sex Differences in Presentation and Outcomes Among Patients With
Type 2 Diabetes and CAD Treated With or Without Prompt RevascularizationJacqueline E. Tamis-Holland, Jiang Lu, Mary Korytkowski, Michelle Magee, William J. Rogers,
Neuza Lopes, Lisa Mighton, Alice K. Jacobs, for the BARI 2D Study Group
Tamis-Holland and colleagues evaluated differences in outcomes among women and men
enrolled in the BARI 2D trial. At enrollment, women were more likely than men to have
angina (67% vs. 58%) despite less disease on angiography. Over 5 years, no sex differences
were observed in BARI 2D study outcomes after adjustment for difference in baseline
variables. However, women reported more angina than men and had lower scores for the
Duke Activity Status Index. These results highlight differences in perceived symptoms, but
not outcomes in men and women with coronary artery disease (CAD) and diabetes.CARDIOMETABOLIC RISK1777Metabolic Risk Factors Do Not Explain Ethnic Differences in Incident CVDTherese Tillin, Alun D. Hughes, Jamil Mayet, Peter Whincup, Naveed Sattar, Nita G. Forouhi,
Paul M. McKeigue, Nish Chaturvedi
Tillin and colleagues sought to determine whether ethnic differences in conventional cardiac
risk factors account for the observed higher rates of coronary heart disease (CHD) in South
Asians (SA) and lower rates in African Caribbeans (AfC) compared to Europeans.
Cardiovascular risk factors were assessed at a mean age of 52 years in a large ethnically diverse
cohort. After adjusting for age, sex, and other risk factors including diabetes, waist:hip ratio,
physical activity, and diet, the risk of CHD was higher in SA and lower in AfC compared to
Europeans. These results confirm that CHD risks are elevated in SA and lower in AfC
compared to European origin populations, but these differences were not explained by
conventional risk factors measured in mid-life.
Editorial Comment: Prakash Deedwania, p. 1787(continued on page A-19)
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cHEART RHYTHM DISORDERS1790Quality of Life Scores Higher With WATCHMAN Device Than With WarfarinOluseun Alli, Shepal Doshi, Saibal Kar, Vivek Reddy, Horst Sievert, Chris Mullin, Vijay Swarup,
Brian Whisenant, David Holmes, Jr
The PROTECT AF trial demonstrated that in patients with nonvalvular atrial fibrillation
(AF) and CHADS2 1, a left atrial appendage (LAA) closure device is noninferior to long-
term warfarin for stroke prevention. For this report, quality of life (QOL) outcomes are
reported. QOL using the Short-Form 12 Health Survey, version 2, was obtained at baseline
and after 12 months in a subset of subjects randomized to warfarin or LAA closure. There
was a significant improvement in QOL in patients randomized to device for total physical
score, physical function, and in physical role limitation compared to warfarin. Patients with
nonvalvular AF at risk for stroke treated with LAA closure have favorable QOL changes at
12 months versus patients treated with warfarin.HEART VALVE DISEASE1799Invasive Hemodynamic Characteristics of Paradoxic Aortic StenosisJuliane Lauten, Christian Rost, Ole A. Breithardt, Christian Seligmann, Lutz Klinghammer,
Werner G. Daniel, Frank A. Flachskampf
Lauten and colleagues hypothesized that some cases of paradoxic severe aortic stenosis (PAS),
defined as aortic valve area (AVA) 1 cm2, mean gradient 40 mm Hg, ejection fraction
50 %, may be due to inaccurate echocardiographic measurements. Echocardiographic and
nvasive hemodynamic data were compared from 58 patients with PAS and 22 patients with
onventionally defined severe aortic stenosis (CAS) who had mean gradient 40 mm Hg. In
AS, AVA by echocardiography and catheterization showed modest agreement, whether
troke volume was measured by oximetry or by thermodilution; mean systolic gradients were
lso very similar. In comparison, in CAS area by echocardiography was 0.72 cm2 and by
atheterization 0.51 cm2 (oximetry) and 0.68 cm2 (thermodilution). Mean systolic gradients
ere similar for CAS patients whether measured invasively or hemodynamically. These results
onfirm the presence of PAS in some patients, arguing against a systematic bias in area
alculation by echocardiography.(continued on page A-20)
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Ehud Schwammenthal
Chronic aortic regurgitation (AR) causes left ventricular (LV) dilation, creating the potential
for functional mitral regurgitation (FMR). Beaudoin and colleagues reviewed the
echocardiograms of 816 patients with at least moderate AR, and 90 patients underwent
3D echocardiography (30 AR, 30 FMR, and 30 controls) to assess mitral valve (MV)
geometry. FMR was present in only 5.6% of AR patients by database review.
Prospectively, only one AR patient had mild FMR despite increased LV end-diastolic
volumes. Total MV leaflet area was largest in AR (31.3% greater than normal),
increasing significantly more than in FMR. These results support the concept that mitral
valve leaflet area increases with chronic AR and prevents FMR.Editorial Comment: Paul A. Grayburn, p. 1817PERIPHERAL VASCULAR DISEASE1820Declining Walking Impairment Questionnaire Scores Predict Increased MortalityAtul Jain, Kiang Liu, Luigi Ferrucci, Michael H. Criqui, Lu Tian, Jack M. Guralnik, Huimin Tao,
Mary M. McDermott
Jain and colleagues studied whether greater declines in the Walking Impairment
Questionnaire (WIQ) domains are associated with higher all-cause and CVD mortality
among individuals with lower extremity peripheral arterial disease (PAD). The WIQ was
completed at baseline and after 2 years. After adjusting for covariates, participants with WIQ
score declines 20 points had all-cause mortality 2 to 4 times higher than those with 20
increases in the 3 domains of speed, stairs, and distance. Patients with PAD who experience
20 point declines in the WIQ scores are at higher risk for mortality than those that have
improvements.
